시장보고서
상품코드
2104597

면역탁도 측정용 시약 시장 : 검사 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Immunoturbidimetry Reagents Market, By Test Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 314 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,633,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,500,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,054,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

면역탁도 측정용 시약 시장 규모는 2025년에 13억 620만 달러로 평가되며, 2026-2033년에 CAGR 6.9%로 확대할 것으로 전망되고 있습니다.

면역탁도 측정용 시약 시장은 항체와 표적 항원 간의 반응으로 인해 발생하는 탁도를 이용하여 특정 단백질이나 바이오마커의 양을 정량하는 면역탁도 측정법에 사용되는 시약으로 구성되어 있습니다. 이러한 시약은 임상화학 분석기에서 C-반응성 단백질(CRP), 면역글로불린, 보체 단백질, 아포지단백질, HbA1c 및 감염증, 심장 질환, 자가면역 질환, 당뇨병, 신장 질환과 관련된 기타 다양한 바이오마커의 농도를 측정하는 데 널리 활용되고 있습니다.

이 업계의 성장은 만성질환 환자 수의 증가, 신속하고 자동화된 진단에 대한 수요 증가, 임상 검사실 인프라 확대, 그리고 고처리량형 임상화학 분석기의 활용 확대와 같은 요인들에 의해 지원되고 있습니다. 또한 시약 배합, 검사실 자동화 기술, 진단 절차의 끊임없는 발전은 물론 의료비 상승 및 건강검진 캠페인이 더해져 향후 수년간 전 세계 면역탁도 측정용 시약 시장의 성장을 촉진할 것으로 예상됩니다.

면역탁도 측정용 시약 시장 - 시장 역학

만성질환 및 감염병 부담 증가가 면역탁도법용 시약 시장의 성장을 촉진

만성질환 및 감염증의 유병률 상승이 예측 기간 중 시장 확대를 지원할 것으로 전망됩니다. 특히 면역탁도법을 이용한 측정은 C-반응성 단백질(CRP), 면역글로불린, 보체 단백질, 아포지단백질, HbA1c 등 다양한 바이오마커를 정량할 수 있으며, 임상 검사실에서 큰 주목을 받고 있습니다. 이 기술을 통해 의료진은 심혈관 질환, 당뇨병, 자가면역 질환, 신장 질환, 세균성 감염증 등 수많은 질환을 조기에 검출하고 모니터링할 수 있게 되어, 적시의 개입을 통해 환자의 예후 개선으로 이어집니다. WHO 통계에 따르면 비감염성 질환(NCD)은 전 세계에서 매년 약 4,100만 명의 사망 원인이 되고 있으며, 이는 전체 사망률의 약 74%를 차지합니다.

정부 및 의료 기관의 진단 검사 시설 확충을 위한 투자 증가와 더불어, 고처리량 분석 장치의 보급이 맞물리면서 전 세계에서 면역탁도법용 시약의 이용 확대가 촉진되고 있습니다. 또한 민감도 향상 및 각종 면역탁도 측정 프로토콜의 표준화를 목표로 한 지속적인 연구개발 활동은 업계 전반의 성장 궤도에 긍정적인 기여를 할 것입니다. 비용 대비 효과가 높은 솔루션과 함께 신속한 결과를 원하는 사람들이 늘어나는 가운데, 이러한 동향은 몇 가지 주요 단백질 마커에 대한 정확한 측정값을 제공할 수 있는 신속 검사 플랫폼에 대한 수요가 지속될 것임을 시사하며, 면역탁도 측정용 시약 분야의 추가적인 확장 계획으로 이어질 것으로 예상됩니다.

면역탁도 측정용 시약 시장 - 시장 세분화 분석:

전 세계 면역탁도법 시약 시장은 검사 유형, 용도, 최종사용자 및 지역을 기준으로 세분화되어 있습니다.

면역탁도법용 시약 시장에서는 검사 유형 부문에서 C-반응성 단백질(CRP)용 시약이 가장 큰 시장 점유율을 차지하고 있습니다. 이는 염증성 질환, 세균 감염증, 심장 질환 및 자가면역 질환의 진단 및 경과 관찰에 CRP 검사가 널리 활용되고 있기 때문입니다. CRP 면역탁도법 검사는 재현성이 높고 신속하며 정확한 정량 결과를 얻을 수 있으므로 자동 임상화학 분석기를 사용하여 수행됩니다. 예를 들어 2025년 3월, 로슈(Roche)는 cobas® 임상화학 분석기 포트폴리오에 Tina-quant® 지단백(a) Gen.2 면역탁도법 어세이를 출시했습니다. 'Tina-quant® 지단백(a) Gen.2' 분석법은 임상 검사실에서 신뢰성 높은 지단백(a) 검사를 제공함으로써 심장 질환 위험 평가의 향상을 목표로 하고 있습니다. 이번 출시는 자동 임상화학 분석을 위한 면역탁도법용 시약이 지속적으로 개발되고 있음을 보여줍니다. 한편, HbA1c용 시약은 당뇨병 유병률 증가에 따라 향후 수년 동안 상당한 성장이 예상됩니다.

용도별로는 일상적인 진단 검사실에서 단백질 마커의 면역탁도법 측정이 증가함에 따라 임상화학 분야가 가장 큰 시장 점유율을 차지하고 있습니다. 심혈관 질환 검사, 자가면역 질환 검사, 감염증 검사, 당뇨병 검사 및 신장 질환 검사의 경우, 만성질환의 부담 증가와 자동화된 임상 검사에 대한 수요 증가로 인해 수요가 늘어날 것으로 전망됩니다. 최종사용자별로는 환자 수의 증가, 자동화 장비의 보급, 그리고 임상 진단 시설에 대한 투자 확대에 힘입어 병원 검사실이 주요 최종사용자가 되고 있습니다. 또한 독립 진단 검사 기관, 학술·연구 기관, 전문 클리닉에서도 향후 수년간 꾸준한 성장이 예상됩니다.

면역탁도법용 시약 시장 - 지역별 분석

면역탁도법용 시약 시장에서 북미는 우수한 의료 인프라, 자동 임상화학 분석 장치의 보급, 진단 검사 건수의 많음, 그리고 주요 체외진단(IVD) 기업의 존재로 인해 가장 큰 시장 점유율을 차지하고 있습니다. 그 밖의 요인으로는 만성질환 발생률의 증가와 검사실 설비 갱신을 위한 지속적인 투자가 꼽힙니다. 미국 질병통제예방센터(CDC)가 발표한 보고서에 따르면 미국 성인의 10명 중 6명이 적어도 하나의 만성질환을 앓고 있으며, 10명 중 4명은 2개 이상의 만성질환을 앓고 있습니다. 만성질환 유병률의 증가는 CRP, HbA1c, 면역글로불린, 아포지단백 검사 등의 바이오마커에 대한 수요를 부추기고 있으며, 그 결과 면역탁도법용 시약의 채택을 촉진하고 있습니다.

유럽 역시 확립된 임상 검사 네트워크, 유리한 의료비 환급 제도, 그리고 질병 예방 및 조기 진단에 대한 정부 투자의 증가에 힘입어 중요한 시장으로 자리 잡고 있습니다. 유럽연합 집행위원회에 따르면 ‘EU4Health 프로그램(2021-2027년)’에서는 EU 회원국 전체의 의료 시스템 강화, 질병 예방 개선 및 진단 능력 향상을 위해 53억 유로가 배정되었습니다. 이 프로그램은 의료 제공자가 첨단 임상 검사 및 자동화된 진단 기술에 대한 접근성을 확대하도록 장려하고 있으며, 그 결과 유럽 전역에서 심혈관 질환, 감염증, 자가면역 질환, 대사성 질환 검사에 면역 탁도법의 활용이 확대되고 있습니다.

목차

제1장 면역탁도 측정용 시약 시장 개요

제2장 개요

제3장 면역탁도 측정용 시약 주요 시장 동향

제4장 면역탁도 측정용 시약 산업 분석

제5장 면역탁도 측정용 시약 시장 : 높아지는 지정학적 긴장의 영향

제6장 면역탁도 측정용 시약 시장 구도

제7장 면역탁도 측정용 시약 시장 : 테스트 유형별

제8장 면역탁도 측정용 시약 시장 : 용도별

제9장 면역탁도 측정용 시약 시장 : 최종사용자별

제10장 면역탁도 측정용 시약 시장 : 지역별

제11장 주요 벤더 분석 : 면역탁도 측정용 시약 산업

제12장 AnalystView의 전방위 전망

KSA 26.08.06

Immunoturbidimetry Reagents Market size was valued at US$ 1,306.2 Million in 2025, expanding at a CAGR of 6.9% from 2026 to 2033.

Immunoturbidimetry Reagents Market consists of reagents that are employed in immunoturbidimetric tests where the turbidity produced from the reaction between antibodies and targeted antigens helps in quantifying the number of specific proteins and biomarkers. These reagents are extensively applied in clinical chemistry analyzers to determine the levels of C-Reactive Protein (CRP), immunoglobulins, complement proteins, apolipoproteins, HbA1c, and various other biomarkers linked to infectious diseases, heart diseases, autoimmune disorders, diabetes, and renal diseases.

The growth of this industry is being augmented by factors such as growing number of patients with chronic diseases, increasing demand for quick and automated diagnostics, expanding base of clinical laboratories, and increased use of high-throughput clinical chemistry analyzers. Additionally, constant developments in reagent formulations, laboratory automation technology, and diagnostic procedures, along with high healthcare expenditure and health screening campaigns, are projected to fuel the growth of global Immunoturbidimetry Reagents Market over the coming years.

Immunoturbidimetry Reagents Market- Market Dynamics

Rising Burden of Chronic and Infectious Diseases Drives Immunoturbidimetry Reagents Market Growth

The rising prevalence of both chronic and infectious diseases is anticipated to fuel market expansion during the forecast period. In particular, Immunoturbidimetric assays have gained significant traction in Clinical Laboratories due to their ability to quantify various Biomarkers such as C- reactive Protein (CRP), Immunoglobulins, Complement Proteins, Apolipoproteins, & HbA1c. This technique enables medical professionals to detect and monitor numerous conditions ranging from Cardiovascular Diseases, Diabetes Mellitus, Autoimmune Disorders, Renal Diseases, Bacterial Infections etc. at an early stage leading to improved patient outcomes through timely interventions. According to WHO statistics, noncommunicable diseases (NCDs) accounts for about 41 million deaths every year globally which constitutes around 74% of total mortality rates.

Increased investment by governments/healthcare Institutions towards diagnostic laboratory infrastructure expansion coupled with widespread adoption of High Throughput Analyzers has catalyzed greater utilization of immunoturbidimetry reagents on a global scale. Moreover, ongoing R&D activities aimed at enhancing sensitivity levels and standardizing various immunoturbidimetric protocols will contribute positively towards overall industry growth trajectory. With more people seeking fast track results accompanied by cost effective solutions, this trend indicates that there will be continued demand for rapid testing platforms capable delivering accurate readings pertaining several key protein markers prompting further expansion plans within immunoturbidimetry reagents sector.

Immunoturbidimetry Reagents Market- Segmentation Analysis:

The Global Immunoturbidimetry Reagents Market is segmented on the basis of Test Type, Application, End User, and Region.

The Immunoturbidimetry Reagents Market includes C-Reactive Protein (CRP) Reagents in the Test Type segment as the dominant market share, attributed to the extensive utilization of CRP tests for diagnosing and monitoring inflammatory diseases, bacterial infections, heart diseases, and autoimmunity. The CRP immunoturbidimetric tests are conducted using automated clinical chemistry analyzers since they yield rapid and accurate quantitative results that are highly reproducible. For example, in March 2025, Roche launched the Tina-quant(R) Lipoprotein (a) Gen.2 immunoturbidimetric assay on the cobas(R) clinical chemistry analyzer portfolio. The Tina-quant(R) Lipoprotein (a) Gen.2 assay aims to enhance the risk assessment of heart diseases by offering reliable Lipoprotein (a) testing in clinical laboratories. This launch shows the continuous development of immunoturbidimetric reagents for automated clinical chemistry analysis. On the other hand, HbA1c Reagents are forecasted to experience significant growth in the coming years due to the rising incidence of diabetes.

Based on Application, Clinical Chemistry enjoys the largest market share due to the increased use of immunoturbidimetric methods for protein markers in routine diagnostics laboratories. Cardiovascular Disease Testing, Autoimmune Disease Testing, Infectious Disease Testing, Diabetes Testing, and Nephrology Testing are expected to enjoy an increase in demand due to the increasing burden of chronic conditions and growing demand for automated laboratory diagnostics. Based on End User, Hospital Laboratories are the major end users due to high patient throughput, availability of automated instruments, and growing investment in clinical diagnostics facilities. The Independent Diagnostic Laboratories, Academic & Research Institutes, and Specialty Clinics will also expected to steady growth in the coming years.

Immunoturbidimetry Reagents Market- Geographical Insights

In Immunoturbidimetry Reagents Market, North America holds the largest market share due to their superior healthcare infrastructure, use of automated clinical chemistry analyzers, diagnostic test volume and presence of major IVD companies. Other factors include increased occurrence of chronic diseases and constant investment in upgrading laboratories. As per the reports published by Centers for Disease Control and Prevention (CDC), six out of ten American adults suffer from at least one chronic disease, while four out of ten suffer from two or more chronic diseases. The rise in prevalence of chronic diseases is fueling the demand for biomarkers, such as CRP, HbA1c, immunoglobulin, and apolipoprotein tests and, thus, driving the adoption of immunoturbidimetry reagents.

Europe represents another significant market, supported by well-established clinical laboratory networks, favorable healthcare reimbursement systems, and increasing government investments in disease prevention and early diagnosis. According to the European Commission, the EU4Health Programme (2021-2027) has allocated €5.3 billion to strengthen healthcare systems, improve disease prevention, and enhance diagnostic capabilities across European Union member states. The program is encouraging healthcare providers to expand access to advanced clinical laboratory testing and automated diagnostic technologies, thereby increasing the utilization of immunoturbidimetric assays for cardiovascular, infectious, autoimmune, and metabolic disease testing across the region.

Immunoturbidimetry Reagents Market- Competitive Landscape:

The competitive landscape of Immunoturbidimetry Reagents Market involves the operation of leading IVD companies engaged in innovations in products, assay standardizations, and development of portfolio of automated clinical chemistry tests. Major competitors of the market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter, Inc. (Danaher Corporation), DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., HORIBA, Ltd., Sekisui Diagnostics, Sentinel Diagnostics S.r.l., and FUJIFILM Wako Pure Chemical Corporation. Competition in the market is being witnessed in the form of development of new reagents, collaborations, approvals, and development of assays that are compatible with analyzers. The continuous development in high sensitivity immunoturbidimetric reagents, laboratory automation, and clinical chemistry systems is helping manufacturers to gain strong positions in the market.

Recent Developments:

In March 2025, Medical & Biological Laboratories (MBL) entered a licensing agreement with Agappe Diagnostics to transfer latex immunoturbidimetric reagent manufacturing technology and supply IVD raw materials. The partnership enabled Agappe to manufacture high-quality latex reagents in India, strengthening domestic diagnostic capabilities while supporting standardized and cost-effective clinical testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Beckman Coulter, Inc. (Danaher Corporation)
  • Thermo Fisher Scientific Inc.
  • DiaSys Diagnostic Systems GmbH
  • Randox Laboratories Ltd.
  • HORIBA, Ltd.
  • Sekisui Diagnostics
  • Sentinel Diagnostics S.r.l.
  • FUJIFILM Wako Pure Chemical Corporation
  • BioSystems S.A.
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Tosoh Corporation
  • Shenzhen Dirui Industrial Co., Ltd.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Trinity Biotech plc
  • DiaSorin S.p.A.
  • QuidelOrtho Corporation
  • BUHLMANN Laboratories AG
  • Werfen
  • Zybio Inc.
  • Maccura Biotechnology Co., Ltd.
  • Beijing Strong Biotechnologies, Inc.
  • Shanghai Kehua Bio-Engineering Co., Ltd.
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033

  • C-Reactive Protein (CRP) Reagents
  • Immunoglobulin Reagents
  • Complement System Reagents
  • Apolipoprotein Reagents
  • HbA1c Reagents
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Clinical Chemistry
  • Autoimmune Disease Testing
  • Cardiovascular Disease Testing
  • Infectious Disease Testing
  • Diabetes Testing
  • Nephrology Testing
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospital Laboratories
  • Independent Diagnostic Laboratories
  • Academic & Research Institutes
  • Specialty Clinics
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Immunoturbidimetry Reagents Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunoturbidimetry Reagents Market Snippet by Test Type
    • 2.1.2. Immunoturbidimetry Reagents Market Snippet by Application
    • 2.1.3. Immunoturbidimetry Reagents Market Snippet by End User
    • 2.1.4. Immunoturbidimetry Reagents Market Snippet by Country
    • 2.1.5. Immunoturbidimetry Reagents Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunoturbidimetry Reagents Key Market Trends

  • 3.1. Immunoturbidimetry Reagents Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunoturbidimetry Reagents Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunoturbidimetry Reagents Market Opportunities
  • 3.4. Immunoturbidimetry Reagents Market Future Trends

4. Immunoturbidimetry Reagents Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunoturbidimetry Reagents Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Immunoturbidimetry Reagents Market Landscape

  • 6.1. Immunoturbidimetry Reagents Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunoturbidimetry Reagents Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
    • 7.1.2. C-Reactive Protein (CRP) Reagents
    • 7.1.3. Immunoglobulin Reagents
    • 7.1.4. Complement System Reagents
    • 7.1.5. Apolipoprotein Reagents
    • 7.1.6. HbA1c Reagents
    • 7.1.7. Others

8. Immunoturbidimetry Reagents Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Clinical Chemistry
    • 8.1.3. Autoimmune Disease Testing
    • 8.1.4. Cardiovascular Disease Testing
    • 8.1.5. Infectious Disease Testing
    • 8.1.6. Diabetes Testing
    • 8.1.7. Nephrology Testing
    • 8.1.8. Others

9. Immunoturbidimetry Reagents Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Hospital Laboratories
    • 9.1.3. Independent Diagnostic Laboratories
    • 9.1.4. Academic & Research Institutes
    • 9.1.5. Specialty Clinics
    • 9.1.6. Others

10. Immunoturbidimetry Reagents Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunoturbidimetry Reagents Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunoturbidimetry Reagents Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunoturbidimetry Reagents Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Immunoturbidimetry Reagents Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Immunoturbidimetry Reagents Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Immunoturbidimetry Reagents Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Siemens Healthineers AG
    • 11.2.4. Beckman Coulter, Inc. (Danaher Corporation)
    • 11.2.5. Thermo Fisher Scientific Inc.
    • 11.2.6. DiaSys Diagnostic Systems GmbH
    • 11.2.7. Randox Laboratories Ltd.
    • 11.2.8. HORIBA, Ltd.
    • 11.2.9. Sekisui Diagnostics
    • 11.2.10. Sentinel Diagnostics S.r.l.
    • 11.2.11. FUJIFILM Wako Pure Chemical Corporation
    • 11.2.12. BioSystems S.A.
    • 11.2.13. Mindray Bio-Medical Electronics Co., Ltd.
    • 11.2.14. Tosoh Corporation
    • 11.2.15. Shenzhen Dirui Industrial Co., Ltd.
    • 11.2.16. HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
    • 11.2.17. Trinity Biotech plc
    • 11.2.18. DiaSorin S.p.A.
    • 11.2.19. QuidelOrtho Corporation
    • 11.2.20. BUHLMANN Laboratories AG
    • 11.2.21. Werfen
    • 11.2.22. Zybio Inc.
    • 11.2.23. Maccura Biotechnology Co., Ltd.
    • 11.2.24. Beijing Strong Biotechnologies, Inc.
    • 11.2.25. Shanghai Kehua Bio-Engineering Co., Ltd.
    • 11.2.26. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기